Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent Deferred RevenueCurrent LeasesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Apyx Medical (APYX) Capital Leases (2019 - 2025)

Apyx Medical's Capital Leases history spans 9 years, with the latest figure at $12000.0 for Q4 2025.

  • For Q4 2025, Capital Leases fell 63.64% year-over-year to $12000.0; the TTM value through Dec 2025 reached $12000.0, down 63.64%, while the annual FY2025 figure was $12000.0, 63.64% down from the prior year.
  • Capital Leases reached $12000.0 in Q4 2025 per APYX's latest filing, down from $18000.0 in the prior quarter.
  • In the past five years, Capital Leases ranged from a high of $107000.0 in Q1 2021 to a low of $12000.0 in Q4 2025.
  • Average Capital Leases over 5 years is $48250.0, with a median of $45500.0 recorded in 2024.
  • Peak YoY movement for Capital Leases: tumbled 93.66% in 2021, then soared 423.08% in 2023.
  • A 5-year view of Capital Leases shows it stood at $18000.0 in 2021, then soared by 305.56% to $73000.0 in 2022, then decreased by 27.4% to $53000.0 in 2023, then tumbled by 37.74% to $33000.0 in 2024, then crashed by 63.64% to $12000.0 in 2025.
  • Per Business Quant, the three most recent readings for APYX's Capital Leases are $12000.0 (Q4 2025), $18000.0 (Q3 2025), and $23000.0 (Q2 2025).